Webinar: #MSCovid19 Question Time – 03/04/20 | Prof Jeremy Hobart, Rachel Dorsey-Campbell & Sarah White
Chairs Please note that all session and slide content are the views of the speakers themselves, not the MS Academy. Ask your questions Please comment below in the discussion section. You can subscribe to email notifications about new comments/replies. → More webinars This meeting has been sponsored by Roche Products Limited. Roche Products Limited has […]
Managing MS and stress amidst the Covid-19 pandemic
With the UK currently advised to remain at home as far as possible for the near future in order to manage the spread of coronavirus, mental health professionals are concerned about the toll this may take on people’s stress levels and overall mental and emotional health. Anxiety and depression are reasonably common symptoms for someone […]
Webinar debate with Profs Klaus Schmierer & David Baker: Should ocrelizumab and cladribine be treated in the same way as alemtuzumab in terms of risk of COVID-19?
Chairs Please note that all session and slide content are the views of the speakers themselves, not the MS Academy. Slides Ask your questions Please comment below in the discussion section. You can subscribe to email notifications about new comments/replies. → More webinars This meeting has been sponsored by Roche Products Limited. Roche Products Limited […]
UK MS Register COVID-19 case report form
On behalf of UK MS Register we would like to ask you to report any cases of MS patients with COVID-19 you have come across. UK MS Register have created a secure, anonymised case report form (CRF) for healthcare professionals to report confirmed infections in patients with MS. It’s a quick survey and an opportunity […]
Webinar: #MSCovid19 Question Time – 27/03/20 | Prof Giovannoni, David Martin, George Pepper, Phillip Anderson, Rachel Dorsey-Campbell
Useful links Gavin Giovannoni’s microsite:sites.google.com/giovannoni.net/clinicspeak-dmt/covid-19-ms Chairs Please note that all session and slide content are the views of the speakers themselves, not the MS Academy. Ask your questions Please comment below in the discussion section. You can subscribe to email notifications about new comments/replies. → More webinars This meeting has been sponsored by Roche Products […]
Survey: How has COVID-19 impacted your MS service?
The MS Academy faculty would like to know how other MS centres are being impacted by the COVID-19 pandemic and if there is anything we can do to share best practice. Please take 2 minutes to fill out our survey. start Survey Thank you for your participation! Our webinars around COVID-19: multiplesclerosisacademy.org/covid-19/
Webinar with Prof Basil Sharrack & Prof John Snowden: AHSCT for highly active and rapidly evolving severe MS during the COVID-19 pandemic
Chairs: Prof Basil Sharrack, Consultant Neurologist & Prof John Snowden, Consultant Haematologist, Sheffield Teaching Hospitals NHS Foundation Trust Please note that all session and slide content are the views of the speakers themselves, not the MS Academy. Slides Ask your questions Please comment below in the discussion section. You can subscribe to email notifications about […]
Chris Wasey’s vlog: My experience with HSCT for MS
This trailer is taken from Chris Wasey’s vlog of his experience with Hematopoietic Stem Cell Treatment (HSCT). Neurology Academy wanted to help clinicians to see beyond the technical elements of this procedure into the reality of a person with MS and their experiences going through it, both as an individual and as a member of […]
‘Dave the dog is worried about coronavirus’
A short, simple online book has been published, aimed at giving children fear-free but truthful information about coronavirus. Written and illustrated by paediatric nurse Molly Watts, she feels it is important to share clear, honest information with her young patients without causing fear or confusion. This latest book, ‘Dave the dog is worried about coronavirus’ […]
Webinar summary: ‘Managing MS remotely during the COVID-19 pandemic’
Neurology Academy is hosting a series of educational webinars over the coming weeks to address some of the challenges with managing specific neurological conditions, or elements of neurological conditions, during the COVID-19 pandemic. The first two, for MS, were ‘Managing MS remotely during the COVID-19 pandemic’ and ‘The use of biomarkers and CSF analysis during […]